These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

812 related articles for article (PubMed ID: 19447413)

  • 41. Prognostic significance of lymphovascular invasion of bladder cancer treated with radical cystectomy.
    Quek ML; Stein JP; Nichols PW; Cai J; Miranda G; Groshen S; Daneshmand S; Skinner EC; Skinner DG
    J Urol; 2005 Jul; 174(1):103-6. PubMed ID: 15947587
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Independent predictors of cancer-specific survival in transitional cell carcinoma of the upper urinary tract: multi-institutional dataset from 3 European centers.
    Novara G; De Marco V; Gottardo F; Dalpiaz O; Bouygues V; Galfano A; Martignoni G; Patard JJ; Artibani W; Ficarra V
    Cancer; 2007 Oct; 110(8):1715-22. PubMed ID: 17724728
    [TBL] [Abstract][Full Text] [Related]  

  • 43. The prognostic impact of pelvic lymph node metastasis and lymphovascular invasion on bladder cancer.
    Herrmann E; Stöter E; van Ophoven A; Bierer S; Bolenz C; Hertle L; Wülfing C
    Int J Urol; 2008 Jul; 15(7):607-11. PubMed ID: 18462352
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Clinical outcome of radical cystectomy for patients with pT4 bladder cancer.
    Furukawa J; Miyake H; Hara I; Takenaka A; Fujisawa M
    Int J Urol; 2008 Jan; 15(1):58-61. PubMed ID: 18184174
    [TBL] [Abstract][Full Text] [Related]  

  • 45. International validation of the prognostic value of lymphovascular invasion in patients treated with radical cystectomy.
    Shariat SF; Svatek RS; Tilki D; Skinner E; Karakiewicz PI; Capitanio U; Bastian PJ; Volkmer BG; Kassouf W; Novara G; Fritsche HM; Izawa JI; Ficarra V; Lerner SP; Sagalowsky AI; Schoenberg MP; Kamat AM; Dinney CP; Lotan Y; Marberger MJ; Fradet Y
    BJU Int; 2010 May; 105(10):1402-12. PubMed ID: 20132195
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Stage-specific impact of extended versus standard pelvic lymph node dissection in radical cystectomy.
    Simone G; Papalia R; Ferriero M; Guaglianone S; Castelli E; Collura D; Muto G; Gallucci M
    Int J Urol; 2013 Apr; 20(4):390-7. PubMed ID: 22970939
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The significance of lymphovascular invasion in transurethral resection of bladder tumour and cystectomy specimens on the survival of patients with urothelial bladder cancer.
    Streeper NM; Simons CM; Konety BR; Muirhead DM; Williams RD; O'Donnell MA; Joudi FN
    BJU Int; 2009 Feb; 103(4):475-9. PubMed ID: 18990174
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Bladder conservation treatment in the elderly population: results and prognostic factors of muscle-invasive bladder cancer.
    Tran E; Souhami L; Tanguay S; Rajan R
    Am J Clin Oncol; 2009 Aug; 32(4):333-7. PubMed ID: 19381080
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Is patient outcome compromised during the initial experience with robot-assisted radical cystectomy? Results of 164 consecutive cases.
    Hayn MH; Hellenthal NJ; Seixas-Mikelus SA; Mansour AM; Stegemann A; Hussain A; Guru KA
    BJU Int; 2011 Sep; 108(6):882-7. PubMed ID: 21166749
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Age-adjusted Charlson comorbidity score is associated with treatment decisions and clinical outcomes for patients undergoing radical cystectomy for bladder cancer.
    Koppie TM; Serio AM; Vickers AJ; Vora K; Dalbagni G; Donat SM; Herr HW; Bochner BH
    Cancer; 2008 Jun; 112(11):2384-92. PubMed ID: 18404699
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Extent of pelvic lymphadenectomy and its impact on outcome in patients diagnosed with bladder cancer: analysis of data from the Surveillance, Epidemiology and End Results Program data base.
    Konety BR; Joslyn SA; O'Donnell MA
    J Urol; 2003 Mar; 169(3):946-50. PubMed ID: 12576819
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Macroscopic, but not microscopic, perivesical fat invasion at radical cystectomy is an adverse predictor of recurrence and survival.
    Bastian PJ; Hutterer GC; Shariat SF; Rogers CG; Palapattu GS; Lotan Y; Vazina A; Amiel GE; Gupta A; Sagalowsky AI; Lerner SP; Schoenberg MP; Karakiewicz PI;
    BJU Int; 2008 Feb; 101(4):450-4. PubMed ID: 17850359
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Association of steroid and xenobiotic receptor (SXR) and multidrug resistance 1 (MDR1) gene expression with survival among patients with invasive bladder carcinoma.
    Rioja J; Bandrés E; Rosell Costa D; Rincón A; López I; Zudaire Bergera JJ; García Foncillas J; Gil MJ; Panizo A; Plaza L; Rioja LA; Berián Polo JM
    BJU Int; 2011 Jun; 107(11):1833-8. PubMed ID: 20840328
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Aggregate lymph node metastasis diameter and survival after radical cystectomy for invasive bladder cancer.
    Stephenson AJ; Gong MC; Campbell SC; Fergany AF; Hansel DE
    Urology; 2010 Feb; 75(2):382-6. PubMed ID: 19819539
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Comparison of laparoscopic and open radical cystoprostatectomy for localized bladder cancer with 3-year oncological followup: a single surgeon experience.
    Hemal AK; Kolla SB
    J Urol; 2007 Dec; 178(6):2340-3. PubMed ID: 17936813
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Surgical margin status after robot assisted radical cystectomy: results from the International Robotic Cystectomy Consortium.
    Hellenthal NJ; Hussain A; Andrews PE; Carpentier P; Castle E; Dasgupta P; Kaouk J; Khan S; Kibel A; Kim H; Manoharan M; Menon M; Mottrie A; Ornstein D; Palou J; Peabody J; Pruthi R; Richstone L; Schanne F; Stricker H; Thomas R; Wiklund P; Wilding G; Guru KA
    J Urol; 2010 Jul; 184(1):87-91. PubMed ID: 20478596
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Standardization of pelvic lymphadenectomy performed at radical cystectomy: can we establish a minimum number of lymph nodes that should be removed?
    Koppie TM; Vickers AJ; Vora K; Dalbagni G; Bochner BH
    Cancer; 2006 Nov; 107(10):2368-74. PubMed ID: 17041887
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Soft tissue surgical margin status is a powerful predictor of outcomes after radical cystectomy: a multicenter study of more than 4,400 patients.
    Novara G; Svatek RS; Karakiewicz PI; Skinner E; Ficarra V; Fradet Y; Lotan Y; Isbarn H; Capitanio U; Bastian PJ; Kassouf W; Fritsche HM; Izawa JI; Tilki D; Dinney CP; Lerner SP; Schoenberg M; Volkmer BG; Sagalowsky AI; Shariat SF
    J Urol; 2010 Jun; 183(6):2165-70. PubMed ID: 20399473
    [TBL] [Abstract][Full Text] [Related]  

  • 59. The optimum timing of radical cystectomy for patients with recurrent high-risk superficial bladder tumour.
    Solsona E; Iborra I; Rubio J; Casanova J; Almenar S
    BJU Int; 2004 Dec; 94(9):1258-62. PubMed ID: 15610101
    [TBL] [Abstract][Full Text] [Related]  

  • 60. Adjuvant chemotherapy for bladder cancer does not alter cancer-specific survival after cystectomy in a matched case-control study.
    Walz J; Shariat SF; Suardi N; Perrotte P; Lotan Y; Palapattu GS; Gupta A; Bastian PJ; Rogers CG; Vazina A; Amiel GE; Sagalowsky AI; Schoenberg M; Lerner SP; Karakiewicz PI
    BJU Int; 2008 Jun; 101(11):1356-61. PubMed ID: 18454792
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 41.